Literature DB >> 8916108

The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment.

P Amouyel1, F Richard, D Cottel, C Amant, V Codron, N Helbecque.   

Abstract

Experimental evidences suggest an implication of the renin angiotensin system (RAS) as a potential determinant of cognitive functions. To explore this hypothesis, we compared the distribution of an insertion (I)/deletion (D) polymorphism of the gene coding for the angiotensin I converting enzyme (ACE), a key enzyme of the RAS, in 228 elderly with cognitive impairment to that of 255 controls. The ACE D allele frequency was higher in the group with cognitive impairment (0.594) than in controls (0.514) (P < 0.02). The ACE DD genotype carriers had an increased risk of cognitive impairment (OR = 1.60, 95% CI (1.04-2.36), P < 0.03), independent of other risk factors of cognitive impairment: age, gender and presence of the apolipoprotein E epsilon 4 allele. This association was stronger in men (OR = 3.25, 95% CI (1.40-7.58), P < 0.006). This result suggests a possible implication of the RAS in human brain and cognitive functions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916108

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Genetic influences on outcome following traumatic brain injury.

Authors:  Barry D Jordan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

2.  Angiotensin I converting enzyme polymorphism effects in patients with normal pressure hydrocephalus syndrome before and after surgery.

Authors:  Maria del Mar Matarín; Maria Antonia Poca; David Bartrés-Faz; Maria Mataró; Imma C Clemente; Cristina Solé-Padullés; Emili González-Pérez; Pedro Moral; Maite Barrios; Carme Junqué; Juan Sahuquillo
Journal:  J Neurol       Date:  2005-02       Impact factor: 4.849

Review 3.  Antihypertensive agents for aging patients who are at risk for cognitive dysfunction.

Authors:  Ihab Hajjar; Michelle Keown; Brandy Frost
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

4.  Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia.

Authors:  H K Wang; H C Fung; W C Hsu; Y R Wu; J C Lin; L S Ro; K H Chang; F J Hwu; Y Hsu; S Y Huang; G J Lee-Chen; C M Chen
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

5.  Association between ACE polymorphism, cognitive phenotype and APOE E4 allele in a Tunisian population with Alzheimer disease.

Authors:  Afef Achouri-Rassas; Nadia Ben Ali; Aroua Cherif; Saloua Fray; Hajer Siala; Nouria Oudiaa Zakraoui; Sondes Hadj-Fredj; Mariem Kechaou; Nadia Anane; Slim Echebi; Taieb Messaoud; Samir Belal
Journal:  J Neural Transm (Vienna)       Date:  2015-10-12       Impact factor: 3.575

6.  ACE polymorphism and use of ACE inhibitors: effects on memory performance.

Authors:  Jaqueline B Schuch; Pamela C Constantin; Vanessa K da Silva; Camila Korb; Daiani P Bamberg; Tatiane J da Rocha; Marilu Fiegenbaum; Alcyr de Oliveira; Luciana A Tisser; Fabiana M de Andrade
Journal:  Age (Dordr)       Date:  2014-04-04

7.  Effects of age, genes, and pulse pressure on executive functions in healthy adults.

Authors:  Naftali Raz; Cheryl L Dahle; Karen M Rodrigue; Kristen M Kennedy; Susan Land
Journal:  Neurobiol Aging       Date:  2009-06-25       Impact factor: 4.673

8.  Does more schooling reduce hospitalization and delay mortality? New evidence based on Danish twins.

Authors:  Jere R Behrman; Hans-Peter Kohler; Vibeke Myrup Jensen; Dorthe Pedersen; Inge Petersen; Paul Bingley; Kaare Christensen
Journal:  Demography       Date:  2011-11

9.  Lack of association between angiotensin-converting enzyme and dementia of the Alzheimer's type in an elderly Arab population in Wadi Ara, Israel.

Authors:  Abdalla Bowirrat; Jing Cui; Kristin Waraska; Robert P Friedland; Marlene Oscar-Berman; Lindsay A Farrer; Amos Korczyn; Clinton T Baldwin
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.